Hopfner Robert Lorne

CIK 0001551966

Director10% Owner

Filings

Latest Dec 22, 2025

Issuers covered

Showing

17 of 17

Page 1

Track record

1 of 9 open-market trades scored (11% price coverage) - 8 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	1	100%	+0.8%	+0.8%	+0.8%	+0.8%
90 days	1	100%	+29.1%	+29.1%	+29.1%	+29.1%
180 days	-	-	-	-	-	-
365 days	-	-	-	-	-	-

Issuers

Companies where Hopfner Robert Lorne has filed

Ticker	Issuer	Filings	Last filed
INZY	Inozyme Pharma, Inc.	9	Jul 3, 2025
RLYB	Rallybio Corp	6	May 15, 2025
EVMN	Evommune, Inc.	2	Dec 22, 2025

All filings

17 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Dec 22, 2025	EVMNEvommune, Inc.	PPurchase	1,000	$17.35	$17,350
Nov 12, 2025	EVMNEvommune, Inc.	CConversion	3,026	-	-
Jul 3, 2025	INZYInozyme Pharma, Inc.	UTender	2,923,110	$4.00	$11,692,440
May 15, 2025	RLYBRallybio Corp	Holdings only	-	-	-
Jan 6, 2025	RLYBRallybio Corp	Holdings only	-	-	-
Jun 20, 2024	INZYInozyme Pharma, Inc.	Holdings only	-	-	-
May 17, 2024	RLYBRallybio Corp	Holdings only	-	-	-
Aug 3, 2023	INZYInozyme Pharma, Inc.	PPurchase	714,285	$4.80	$3,428,568
Jun 15, 2023	INZYInozyme Pharma, Inc.	Holdings only	-	-	-
May 19, 2023	RLYBRallybio Corp	Holdings only	-	-	-
May 15, 2023	INZYInozyme Pharma, Inc.	PPurchase	228,702	$6.25	$1,429,388
Mar 30, 2023	INZYInozyme Pharma, Inc.	PPurchase	344,592	$4.5379	$1,563,724
Mar 29, 2023	INZYInozyme Pharma, Inc.	PPurchase	156,766	$4.1612	$652,335
Jun 14, 2022	INZYInozyme Pharma, Inc.	Holdings only	-	-	-
May 26, 2022	RLYBRallybio Corp	Holdings only	-	-	-
Apr 20, 2022	INZYInozyme Pharma, Inc.	PPurchase	1,070,000	$3.69	$3,948,300
Jan 5, 2022	RLYBRallybio Corp	Holdings only	-	-	-

Showing 1-17 of 17

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value